ECP
CELG

Empyrean Capital Partners’s Celgene Corp CELG Stock Holding History

Empyrean Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,542,000
Closed -$153M – 79
2019
Q3 		$153M Hold
1,542,000
– – 7.96% 2
2019
Q2 		$143M Buy
1,542,000
+442,000
+40% +$42M 6.34% 5
2019
Q1 		$104M Buy
+1,100,000
New +$96.2M 4.73% 4

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Empyrean Capital Partners's CELG Position: Q4 2019 in Review

Empyrean Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,542,000 shares — an estimated $153M sold.

Empyrean Capital Partners first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $153M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Empyrean Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,542,000 Celgene Corp shares in Q4 2019, an estimated $153M.
  • Empyrean Capital Partners first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Empyrean Capital Partners's Celgene Corp position peaked at $153M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Empyrean Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.